| Southeast | South | North/Northeast | Mid-west | P Value |
---|---|---|---|---|---|
N(%) | 1,424(39.7) | 820 (22.8) | 1,113(31.0) | 234 (6.5) | Â |
Glycemic Control | Â | Â | Â | Â | Â |
HbA1c | Â | ||||
Frequency of Complete Records n (%) | 1,356 (95.2) | 809 (98.7) | 978(87.9) | 210 (89.7) | <0.001 |
Mean (SD) | 9.1 ± 2.3 | 9.4 ± 2.1# | 9.4 ± 2.6# | 9.1 ± 2.6 | 0.002 |
Patients at Goal | 276 (20.6) | 98 (12.2)* | 154 (20.4) | 42 (21.4) | <0.001 |
FPG | Â | ||||
Frequency of Complete Records n (%) | 1,251 (87.9) | 803 (97.9) | 1,016 (91.3) | 187 (79.9) | Â |
Mean (SD) | 187.3 (108.4)# | 174.4 (94.4) | 185.3 ± 108.2# | 179.0 ± 102.60 | <0.001 |
Patients at Goal | 332 (26.6) | 293 (36.5) | 301 (29.6) | 53 (28.3) | <0.001 |
Cardiovascular Risk Factors | Â | Â | Â | Â | Â |
BMI | 1,419 (99.6) | 819 (99.9) | 1,104 (99.2) | 226 (96.6) | Â |
Frequency of Complete Records n (%) | Â | ||||
Mean (SD) | 21.9 ± 4.4 | 22.2 ±3.3* | 20.9 ± 4.2 | 21.7 ± 4.6 | 0.01 |
Patients at Goal | 942 (66.4) | 547 (66.8) | 823 (74.5)* | 150 (66.4) | 0.009 |
sBP | Â | Â | Â | Â | Â |
Frequency of Complete Records n (%) | 1,393 (97.8) | 811 (98.9) | 1,040 (93.4) | 193 (82.5) | Â |
Mean (SD) | 111.4 ± 16.0 | 111.7 ± 17.9 | 109.1 ± 17.4* | 115.8 (19.3) | <0.001 |
Patients at Goal | 1,159 (83.2) | 667 (82.2) | 893 (85.9) | 148 (76.7) | 0.009 |
dBP | Â | Â | Â | Â | Â |
Frequency of Complete Records n (%) | 1,392 (97.8) | 811 (98.9) | 1,032 (92.7) | 191 (81.6) | Â |
Mean (SD) mmHg | 71.4 ± 11.02 | 71.4 ± 11.7 | 70.9 ± 12.2 | 71.8 ± 12.2 | 0.31 |
Patients at Goal | 890 (63.9) | 523 (64.5) | 709 (68.7) | 137 (71.7)* | 0.003 |
Triglycerides (mg/dl) | Â | Â | Â | Â | Â |
Frequency of Complete Records n (%) | 1,262 (88.6) | 496 (60.5) | 853 (76.6) | 181 (77.4) | Â |
Mean (SD) | 87.7 ± 69.1 | 95.3 ± 72.1 | 103.5 ± 76.9 | 91.6 ± 58.1 | 0.006 |
Patients at Goal | 986 (78.1) | 407 (82.1) | 589 (69.1)* | 145 (80.1) | 0.001 |
HDL (Cholesterol) | Â | Â | Â | Â | Â |
Frequency of Complete Records n (%) | 1,227 (86.2) | 487 (59.4) | 838 (75.3) | 180 (76.9) | Â |
Mean (SD) | 53.3 ± 14.8* | 53.9 ± 15.2*** | 50.1 ± 14.1 | 52.0 ± 12.1 | 0.01 |
Patients at Goal n (%) | 984 (80.2)**** | 369 (75.8) | 604 (72.1) | 141 (78.3) | 0.004 |
LDL Cholesterol | Â | Â | Â | Â | Â |
Frequency of Complete Records n (%) | 1,218 (85.5) | 483 (58.9) | 821 (73.8) | 179 (76.5) | Â |
Mean (SD) | 96.9 ± 33.1*** | 102.6 ± 31.3 | 102.9 ± 35.7 | 102.1 ± 28.3 | <0.002 |
Patients at Goal n (%) | 730 (59.9)* | 241 (49.9) | 422 (51.4) | 89 (49.7) | <0.001 |
Non-HDL Cholesterol | 1,227 (86.2) | 487(59.4) | 835 (75) | 180 (76.9) | Â |
Frequency of Complete Records n (%) | Â | Â | Â | Â | Â |
Mean (SD) | 113.7 ± 39.1 ### | 121.6 ± 37.5* | 122.0 ± 43.1* | 119.5 ± 32.7 | 0.001 |
Patients at Goal | 924 (75.3)**** | 322 (66.1) | 529 (63.4) | 123 (68.3) | <0.001 |
Smoking Status (y), N (%) | 56 (4.1) | 60 (7.5) | 24 (2.2) | 10 (4.5) | 0.000 |
Chronic Complications | Â | Â | Â | Â | Â |
Feet examination | Â | ||||
Yes, n(%) | 1,071 (75.2)* | 465 (56.7) | 588 (52.8) | 128 (54.7) | <0.001 |
Fundoscopy y, n(%) | Â | ||||
Yes,n (%) | 714 (50.1)+ | 462 (56.3)* | 427 (38.4) | 80 (34.2) | <0.001 |
Urine Albumin | Â | ||||
Yes, n (%) | 661 (46.4)+ | 484 (59)* | 361 (32.4) | 72 (30.8) | <0.001 |